TortsProf Blog

Editor: Christopher J. Robinette
Widener Commonwealth Law School

Tuesday, October 27, 2009

South Carolina Settles Zyprexa Off-Label Marketing Case for $45 Million

Sometimes it is better to wait on the sidelines... South Carolina did not participate in the collective suit by 32 states against Pfizer for its off-label marketing of the anti-psychotic drug, Zyprexa.   If South Carolina has joined that suit, it would have received around $4.5 million.   Instead, it brought its own lawsuit and now reports a $45 million settlement with Pfizer.  The Post and Courier has more. 

As of September 30th, Legal Newsline reportedthree additional Zyprexa cases remained pending:  Mississippi before Judge Weinstein; Arkansas and Pennsylvania in state court. 


Current Affairs, MDLs and Class Actions, Products Liability | Permalink

TrackBack URL for this entry:

Listed below are links to weblogs that reference South Carolina Settles Zyprexa Off-Label Marketing Case for $45 Million:


Zyprexa is marketed by Eli Lilly, not Pfizer.

Posted by: CJ | Mar 23, 2011 9:20:04 AM

Post a comment